Related references
Note: Only part of the references are listed.The Effect of Testosterone on Cardiovascular Biomarkers in the Testosterone Trials
Emile R. Mohler et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes
Kristina Groti et al.
AGING MALE (2018)
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society* Clinical Practice Guideline
Shalender Bhasin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome
M. I. Maiorino et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2018)
Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in Men with Hypogonadism: A Real-Life Observational Registry Study Setting Comparing Treated and Untreated (Control) Groups
Abdulmaged M. Traish et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2017)
Impact of various progestins with or without transdermal testosterone on gonadotropin levels for non-invasive hormonal male contraception: a randomized clinical trial
M. Zitzmann et al.
ANDROLOGY (2017)
New insights into the role of adipose tissue in thrombosis
Gemma Vilahur et al.
CARDIOVASCULAR RESEARCH (2017)
Early weight loss predicts the reduction of obesity in men with erectile dysfunction and hypogonadism undergoing long-term testosterone replacement therapy
Mahmoud Salman et al.
AGING MALE (2017)
Statin, testosterone and phosphodiesterase 5-inhibitor treatments and age related mortality in diabetes
Geoffrey Hackett et al.
WORLD JOURNAL OF DIABETES (2017)
The Role of Adipocytokines in Coronary Atherosclerosis
Luca Liberale et al.
CURRENT ATHEROSCLEROSIS REPORTS (2017)
Association of general and abdominal obesity with age, endocrine and metabolic factors in Asian men
Victor Hng Hang Goh et al.
AGING MALE (2016)
Markers of Atherosclerotic Disease: What do they Mean? Current Opinion Future Trends
Aurelio Leone
CURRENT PHARMACEUTICAL DESIGN (2016)
Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes
Sandeep Dhindsa et al.
DIABETES CARE (2016)
Testosterone supplementation and body composition: results from a meta-analysis study
Giovanni Corona et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Effects of tadalafil treatment combined with physical activity in patients with low onset hypogonadism: results from a not-randomized single arm phase 2 study
Rosita A. Condorelli et al.
AGING MALE (2016)
Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters
Aksam Yassin et al.
AGING MALE (2016)
Clinical relevance of high sensitivity C-reactive protein in cardiology
Dalia Adukauskiene et al.
MEDICINA-LITHUANIA (2016)
Clinical relevance of high sensitivity C-reactive protein in cardiology
Dalia Adukauskiene et al.
MEDICINA-LITHUANIA (2016)
Endothelial function in men with type 2 diabetes without clinical signs of cardiovascular disease
Irina A. Khripun et al.
DIABETES MELLITUS (2016)
Late-onset hypogonadism among old and middle-aged males with prediabetes in Polish population
Michal Rabijewski et al.
AGING MALE (2015)
Erectile dysfunction is a prognostic indicator of comorbidities in men with late onset hypogonadism
Yousef Almehmadi et al.
AGING MALE (2015)
The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease
Abdulmaged M. Traish et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2015)
Effects of testosterone treatment on glucose metabolism and symptoms in men with type 2 diabetes and the metabolic syndrome: a systematic review and meta-analysis of randomized controlled clinical trials
Mathis Grossmann et al.
CLINICAL ENDOCRINOLOGY (2015)
The impact of metabolic syndrome on serum total testosterone level in patients with erectile dysfunction
Yilmaz Aslan et al.
AGING MALE (2014)
Testosterone and type 2 diabetes in men
Allan Mazur et al.
AGING MALE (2014)
Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
Xiang Cai et al.
ASIAN JOURNAL OF ANDROLOGY (2014)
Characteristics of Compensated Hypogonadism in Patients with Sexual Dysfunction
Giovanni Corona et al.
JOURNAL OF SEXUAL MEDICINE (2014)
Testosterone and cardiovascular disease
T. Hugh Jones
LANCET DIABETES & ENDOCRINOLOGY (2014)
Guideline Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes
Itamar Raz
DIABETES CARE (2013)
Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes
Vakkat Muraleedharan et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study
E. M. Camacho et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Resistin: functional roles and therapeutic considerations for cardiovascular disease
Md S. Jamaluddin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
The role of leptin in glucose homeostasis
Heather C. Denroche et al.
JOURNAL OF DIABETES INVESTIGATION (2012)
Testosterone as Potential Effective Therapy in Treatment of Obesity in Men with Testosterone Deficiency: A Review
Farid Saad et al.
CURRENT DIABETES REVIEWS (2012)
Low Testosterone Associated With Obesity and the Metabolic Syndrome Contributes to Sexual Dysfunction and Cardiovascular Disease Risk in Men With Type 2 Diabetes
Christina Wang et al.
DIABETES CARE (2011)
Endogenous testosterone levels and cardiovascular disease in healthy men
Kevin S. Channer
HEART (2011)
Resistin Induces Monocyte-Endothelial Cell Adhesion by Increasing ICAM-1 and VCAM-1 Expression in Endothelial Cells via p38MAPK-Dependent Pathway
Wei-Yen Hsu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Diagnosis and Classification of Diabetes Mellitus
DIABETES CARE (2010)
Characteristics of Secondary, Primary, and Compensated Hypogonadism in Aging Men: Evidence from the European Male Ageing Study
Abdelouahid Tajar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly Men
Frederick C. W. Wu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Testosterone deficiency, insulin resistance and the metabolic syndrome
Michael Zitzmann
NATURE REVIEWS ENDOCRINOLOGY (2009)
Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: The European Male Aging Study
Frederick C. W. Wu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Targeting selectins and selectin ligands in inflammation and cancer
Steven R. Barthel et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men
Thomas G. Travison et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-α-activated vascular endothelium under flow
L Yang et al.
BLOOD (2005)
The role of selectins in inflammation and disease
K Ley
TRENDS IN MOLECULAR MEDICINE (2003)
Androgens and coronary artery disease
FCW Wu et al.
ENDOCRINE REVIEWS (2003)
Endothelial dysfunction - A marker of atherosclerotic risk
PO Bonetti et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes
O Barreiro et al.
JOURNAL OF CELL BIOLOGY (2002)
Share Paper
